Cumberland Pharmaceuticals Inc.
CPIX
$2.28
$0.125.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.94M | -740.70K | 1.26M | -1.90M | -1.54M |
| Total Depreciation and Amortization | 1.32M | 1.32M | 1.32M | 1.78M | 1.40M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.50K | 8.50K | 196.80K | -398.70K | -712.50K |
| Change in Net Operating Assets | 808.40K | 256.90K | 1.13M | 2.43M | 1.33M |
| Cash from Operations | 187.20K | 843.80K | 3.90M | 1.90M | 475.50K |
| Capital Expenditure | -23.80K | -26.50K | -47.60K | -2.30K | -15.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -667.00K | 312.40K | -1.18M | -24.50K | 205.00K |
| Cash from Investing | -690.80K | 285.90K | -1.23M | -26.80K | 189.60K |
| Total Debt Issued | -- | -- | -- | 5.50M | 10.99M |
| Total Debt Repaid | 0.00 | 0.00 | -10.04M | -6.32M | -10.99M |
| Issuance of Common Stock | 0.00 | 0.00 | 5.27M | -- | -- |
| Repurchase of Common Stock | -10.40K | -7.20K | -245.90K | -98.40K | -98.80K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -376.40K | -143.60K | -511.10K | -464.60K | -438.00K |
| Cash from Financing | -386.90K | -150.80K | -5.53M | -1.38M | -536.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -890.50K | 978.90K | -2.86M | 499.40K | 128.30K |